Moneycontrol PRO
UPCOMING EVENT:Attend Traders Carnival Live. 3 days 12 sessions at Rs.1599/-, exclusive for Moneycontrol Pro subscribers. Register now!

Buy Granules India; target of Rs 430: ICICI Direct

ICICI Direct is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 430 in its research report dated July 29, 2021.

August 04, 2021 / 05:30 PM IST
  • bselive
  • nselive
Todays L/H

ICICI Direct's research report on Granules India

Granules is a large-scale vertically integrated company that manufactures API, intermediates and finished dosages and has seven manufacturing facilities along with B2B & B2C marketing & distribution. Revenues: Formulations – 52%, API (API+PFI) – 48% Top five products (Paracetamol, Ibuprofen, Metformin, Methocarbamol, Guaifenesin) contributed 84% to FY21 revenues


We change our rating from HOLD to BUY due to better clarity and visibility We value Granules at Rs 430 i.e. 15x P/E on FY23E EPS

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Aug 4, 2021 05:30 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark